Rallybio Corporation
RLYB • NASDAQ
Rallybio Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen Uden, with a market cap of $43.9M.
Market Cap$43.9M
Employees30.0
CEOStephen Uden
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Rallybio Corporation FAQ
Common questions about Rallybio Corporation
Rallybio Corporation is scheduled to report earnings for Q1 2026 on May 12, 2026 before market open. Analysts estimate revenue of $226.7K.
Rallybio Corporation has approximately 30 employees.